Beta Bionics target price raised to $24 from $20
BBNX•Piper Sandler raised its target price for Beta Bionics to $24 from $20.
Related News
Esquire Financial Holdings price target raised to $143 from $137
ESQ•
Anthropic reportedly picked JPMorgan to lead IPO’s US retail offering
JPM•
Travel + Leisure Co: JP Morgan raises target price to $72 from $70
TNL•
Japan bond yields rise as haven demand recedes, BOJ meeting looms
TLT•
US closes $5.1 billion loan to Alliant Energy for new gas power generation, energy storage
LNT•